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Abstract  
Background:  Surgical site infections (SSIs) are one of the most common hospital 
acquired infections. To reduce SSIs prophylactic intraoperative wound irrigation 
(pIOWI) has been advocated, although results are equivocal. To develop 
recommendations for the new World Health Organization (WHO) SSI prevention 
guidelines, a systematic literature review and a meta-analysis were conducted on 
the effectiveness of pIOWI using different agents to reduce SSI. 
Methods: Pubmed, Embase, CENTRAL, CINAHL, and WHO databases were searched. 
Randomized controlled trials (RCTs) comparing either pIOWI to no pIOWI, or to 
pIOWI using different solutions and techniques, were included with SSI as the 
primary outcome. Meta-analyses were performed and odds ratios (OR) and the 
mean difference with 95% confidence intervals (CI) were extracted and pooled with 
a random effects model. 
Results: Twenty-one studies were available and a distinction was made between 
intraperitoneal, mediastinal and incisional wound irrigation. Low quality of evidence 
demonstrated a statistically significant benefit for incisional wound irrigation with an 
aqueous povidone iodine (PVP-I) solution in clean and clean contaminated wounds 
(OR 0.31 (95% CI: 0.13-0.73), p=0.007; 50 fewer SSIs per 1.000 procedures (from 19 
fewer to 64 fewer)). Antibiotic irrigation had no significant effect in reducing SSIs (OR 
1.16 (95% CI: 0.64-2.12, p=.63). 
Conclusion: Low quality evidence suggests considering the use of prophylactic 
incisional wound irrigation to prevent SSI with an aqueous povidone iodine solution. 
Antibiotic wound irrigation does not show a benefit and is therefore discouraged.   
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Introduction 
Surgical site infections (SSIs) are an adverse outcome of surgery accounting for the 
majority of healthcare associated infections around the world (1-3). In developing 
countries, more than one in ten of all surgical procedures is complicated by a SSI (2). 
Although the overall risk of SSIs is much lower in developed countries, they remain a 
serious threat to patient safety (1, 3). SSIs cause increased morbidity, mortality and 
prolonged hospital stay (1, 4, 5). The average SSI is associated with approximately 
one additional week of hospitalization and increases mortality risk 2- to 11-fold as 
compared to uninfected surgical patients (5). Moreover, SSIs increase healthcare 
costs in the US up to $1.6 billion per year (4). Many factors have been associated 
with the risk of SSI and consequently a range of preventive measures has been 
proposed. One of these preventive measures is prophylactic intraoperative wound 
irrigation (pIOWI), a seemingly simple intervention defined by the flow of a solution 
across the surface of an open wound to achieve wound hydration. It physically 
removes and dilutes body fluids, bacteria and cellular debris and additionally may 
have a bactericidal effect when additives as antibiotics or antiseptic agents are used 
(see table 1 for an overview of definitions used).  Up to 97% of the surgeons 
commonly practice IOWI (6, 7). Nonetheless, it is not part of general practice in every 
country or hospital. Moreover, methods vary depending on the patient population, 
surface of application, technique and solutions used. Similar variations in 
methodology and results can be observed in studies investigating the effect of IOWI 
(8). 
 Among the available guidelines on SSI prevention, few have addressed the topic of 
IOWI and give contradictive recommendations. The guidelines by the United 
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Kingdom National Institute for Health and Care Excellence (NICE) issued in 2008, 
updated in 2013, advised against IOWI and intraperitoneal lavage (9). In contrast, the 
2014 guidelines of the Society for Healthcare Epidemiology of America (SHEA) and 
the Infectious Diseases Society of America  (IDSA) recommend using antiseptic 
wound lavage (10). Many of the solutions commonly used for irrigation are not 
licensed for open wounds by the United States (US) Food and Drug Administration 
(11).  
In 2015 a meta-analysis has been published to determine the current state of 
knowledge on pIOWI (8). However, that review does not take into account that 
(other) infection prevention measures among included studies have improved over 
decades. Therefore, the presented evidence may not be generalizable to current 
standard of care (i.e., no appropriate standard systemic antibiotic prophylaxis). 
Importantly, the previous review has included studies where pIOWI represents a 
therapeutic intervention for infection rather than a prophylactic measure. Also, a 
substantial heterogeneity between studies has not been accounted for as the 
previous review does not account for differences in irrigation solutions and in 
application methods.  For the purpose of developing recommendations for the new 
World Health Organization (WHO) SSI prevention guidelines (12, 13), a systematic 
literature review and meta-analysis were conducted. In present systematic review 
we aim to assess all available data reasonably applicable to current standard of care 
and clarify the effect of pIOWI on the incidence of surgical site infection in all surgical 
populations, while accounting for inter-study differences in application method and 
solution. 
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Methods 
 
The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
guidelines were followed (14).    
Search strategy and selection criteria 
The following databases were searched: Medline (PubMed); Excerpta Medica 
Database (EMBASE); Cumulative Index to Nursing and Allied Health Literature 
(CINAHL); Cochrane Central Register of Controlled Trials (CENTRAL); and WHO 
regional medical databases. No time limit was used because most studies were 
published before 1990. Language was restricted to English, French, German and 
Spanish. A comprehensive list of search terms was used, including Medical Subject 
Headings (MESH), the complete search is included in appendix A. 
 
Two independent reviewers screened titles and abstracts of retrieved references for 
potentially relevant studies. The full text of these articles was obtained and 
independently reviewed for eligibility based on inclusion criteria. Duplicate studies 
were excluded. Only randomized studies investigating pIOWI as described in Table 1 
were included.  Studies investigating the topical application of antibiotics and 
antiseptics (e.g., powder, gels, sponges) without the mechanical effect of irrigation, 
physically rinsing and diluting the bacterial load, were not included. To ensure that 
only evidence reasonably relevant to the current standard of care was included in 
our analyses, description of appropriate administration of preoperative antibiotic 
prophylaxis (i.e., before incision and intravenous) was a minimum requirement for 
inclusion. In addition, studies where the irrigated field was infected prior to the start 
of surgery and wound irrigation, represented a therapeutic intervention rather than 
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a prophylactic measure and were also excluded. Wound contamination was ranked 
according to the US Centers for Disease Control and Prevention (CDC) wound 
classification(15).  As described in table 1, wound class I-III were considered not 
infected and therefore irrigation of the contaminated field a prophylactic measure, 
whereas CDC Wound class IV was considered a pre-existent infection and therefore 
irrigation of the contaminated field represented a therapeutic intervention. 
Irrigation of the newly made incisional wound was always considered prophylactic, 
regardless of the wound classification, as the incisional wound did not exist prior to 
the procedure and pre-existent infection would be impossible. For example, 
peritoneal cavity irrigation of a dirty, infected abdomen (CDC Wound class IV) 
represents a therapeutic intervention. In contrast, in the same procedure incisional 
wound irrigation was considered a prophylactic measure.  
 
Data extraction and assessment of study quality 
Data were extracted from the text, according to a pre specified data abstraction 
form including design, publication date, scope, number of patients, contamination 
according to the US CDC wound classification (15), irrigation surface, type of 
intervention (solution, application, volume), type of control, Follow-up, primary 
outcome, results and adverse events (AE) (appendix B). The Cochrane Collaboration’s 
tool(16) for assessing risk of bias was assessed for the quality of the studies. Any 
disagreements were resolved through discussion or after consultation with the 
senior author, when necessary. Publication bias was assessed using a funnel plot 
(17). The Grading of Recommendations Assessment, Development and Evaluation 
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(GRADE) methodology (GRADE Pro software, http://gradepro.org/) (18) was used to 
assess the quality of the body of retrieved evidence. 
 
Synthesis of results  
Trials were grouped in comparisons according to irrigation location and their 
intervention and control arm. Of each comparison meta-analysis were performed 
using Review Manager (RevMan, Version 5.3.  Copenhagen: The Nordic Cochrane 
Centre, The Cochrane Collaboration, 2014.) as appropriate. If only one study no data 
could be pooled, but data were plotted as forest plot for illustrative purposes.  Odds 
ratios (OR) and the mean difference with 95% confidence intervals (CI) were 
extracted and pooled for each comparison with a random effects model (Mantel-
Haenszel method) to account for potential heterogeneity (19). Forest plots were 
constructed and P< 0.05 was considered to be statistically significant. Heterogeneity 
was assessed using the I2 statistic. I2 of >60% was assessed as serious inconsistency.  
When inconsistency was detected stratified subgroup analysis where made for 
wound contamination and for irrigation solution. 
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Results 
Study selection 
We identified 955 studies. Hundred thirteen were assessed for full review. Twenty-
one randomized controlled trials (RCTs) were found eligible for full critical appraisal. 
The process of selection is summarized in Figure 1. Reasons for exclusion after full 
text assessment are described in appendix C.  
 
Study characteristics 
In total we identified 21 RCTs (20-40) (6224 patients) comparing pIOWI to no pIOWI 
or to pIOWI using different solutions and techniques, in patients undergoing various 
surgical procedures with SSI as an outcome. All but two (27, 28) were single center 
RCTs. There was substantial heterogeneity in the study protocols. A distinction was 
made between peritoneal cavity, mediastinal cavity and incisional wound irrigation. 
Other main differences were the composition of the irrigation fluid, and the type of 
surgery with associated contamination. Due to this heterogeneity of the evidence, 
nine separate comparisons were composed.  Five studies describing intraoperative 
peritoneal cavity irrigation (20-24) comparing saline solution vs. no irrigation (20), 
taurolidine vs. saline solution (21) and antibiotic irrigation vs saline or no irrigation 
(22-24);  fifteen describing incisional wound irrigation (25-39)  comparing saline 
solution vs. no irrigation (25), syringe pressure irrigation with saline solution vs. no 
irrigation (26), pulse pressure irrigation with saline solution vs. normal saline solution 
(27, 28), aqueous povidone iodine (PVP-I) vs. saline solution (29-35) and antibiotic vs. 
saline solution or no irrigation (22, 36-39); and one study describing intraoperative 
mediastinal cavity irrigation (40) comparing  aqueous PVP-I vs. saline solution. Most 
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studies were conducted in patients undergoing abdominal surgery (20-24, 26, 28, 31, 
32, 36, 37) but spine (33, 34), orthopedic (27, 35, 39), gynecologic (25), vascular (38), 
thoracic (40) and general surgery (29, 30) were also included. Of the included studies 
3 RCTs (20, 23, 31) described sterility of the irrigation fluid. The other studies did not 
report whether the irrigation fluid was sterile or not.  The evidence table with study 
characteristics is summarized in Table 2 and entirely presented in Appendix B. 
 
Risk of bias 
The results of the risk of bias evaluation are presented in Table 3. Overall there was 
serious risk of bias, predominantly due to unclear or high risk of selection and 
performance bias. Publication bias could not be detected or excluded. There was an 
insufficient number of studies included in the separate meta-analyses for 
appropriate interpretation of the funnel plots.  
 
Data and analyses 
A summary of the evidence is presented in Table 4. For an extensive overview of all 
nine comparisons, corresponding data and meta-analyses we refer to appendix D.   
 No effective strategy for the reduction of SSIs with prophylactic peritoneal cavity 
irrigation was identified.  
Regarding incisional wound irrigation, mere saline irrigation was not effective in 
reducing SSIs (25). However, when the saline solution was applied with a syringe to 
generate some pressure (26) a reduction in the risk of SSI compared to no irrigation 
was shown in one study (OR 0.35 (95% CI: 0.19-0.65); P=0.0009). This benefit was 
also demonstrated when pulse pressure irrigation with saline was compared with 
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normal saline irrigation in a meta-analysis of two RCTs (27, 28) (OR 0.30 (95% CI: 
0.08-0.86); p=0.0003).  
Irrigation with aqueous povidone iodine demonstrated a significant benefit when 
compared with saline solution irrigation in a meta-analysis of 7 RCTs (29-35) (OR 0.31 
(95% CI: 0.13-0.73); p=0.007; Figure 2a-c). This effect equals 50 fewer SSIs per 1.000 
procedures (from 19 fewer to 64 fewer) (appendices D and E comparison 7). The 
results where stratified according to subgroups based on wound contamination 
(Figure 2b) and povidone iodine concentration (Figure 2c) to account for 
heterogeneity in the pooled analysis (I2=63%). Thereby, heterogeneity decreased to 
an I2 of 43 %. The effect of irrigation with aqueous povidone iodine on SSIs was 
attributable to incisional wound irrigation in clean and clean-contaminated 
procedures with PVP-I 10% and PVP-I 0.35%. No dose response effect was seen.  
Antibiotic irrigation of the incisional wound showed no effect on SSI rate compared 
to no irrigation or saline irrigation in a meta-analysis of five RCTs (22, 36-39) (OR 1.16 
95% CI: 0.64-2.12 p=0.63) (Figure 3). This lack of effect equals 12 more SSIs per 1.000 
(from 27 fewer to 76 more) (appendices D and E comparison 8).  
Only one study reported on mediastinal irrigation with aqueous povidone iodine 
compared to normal saline irrigation and showed no benefit (40) . 
 
Adverse events 
Among the included studies, six studies (29, 31, 33, 34, 36, 41) reported no adverse 
events attributable to the intervention. Among these, two studies (33, 34) 
investigating PVP-I wound irrigation in spinal surgery specifically reported no 
difference in fusion time or bone quality. One study (31) investigating PVP-I wound 
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irrigation in abdominal surgery specifically reports transient serum iodine elevation 
to a nine fold (median: 162 mcg/dl, range 27-1170 mcg/dl), but no clinical signs of 
toxicity. After seven days, serum iodine levels returned to pre-operative ranges.   
 
GRADE 
GRADE tables with full assessment of the individual comparisons are presented in 
appendix E. Overall the quality of evidence was assessed as moderate to very low 
due to the serious risk of bias and serious imprecision.  
 
Discussion  
 
Low quality evidence shows that prophylactic incisional wound irrigation with 
aqueous PVP-I solution, has a significant benefit on SSI rate, particularly in clean and 
clean-contaminated wounds. No dose response effect was detected. With respect to 
incisional wound irrigation with saline, moderate to very low quality of evidence 
shows a significant effect on SSI rate when applied with force or using pulse 
pressure, but not with regular irrigation. There is no significant benefit for the use of 
antibiotic solutions for pIOWI or for the use of pIOWI in the abdomen or 
mediastinum.  
Although recommendations from existing guidelines are conflicting (9, 10) and 
recent  well-designed RCTs are lacking, up to 97% of the surgeons irrigate wounds in 
an effort to reduce the risk of SSI (6, 7). The most commonly used irrigation solution 
is saline followed by irrigation with aqueous PVP-I solutions or antibiotic solutions (6, 
42, 43).  
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The efficacy and clinical safety of irrigation with these solutions has been under 
debate (11, 44). PVP-I is in varying concentrations rapidly effective against a broad 
spectrum of pathogens, Methicillin-resistant Staphylococcus aureus (MRSA) included 
(45, 46).  However, some in vitro studies (47-49) have reported a negative effect of 
PVP-I on tissue regeneration and older case studies report serum iodine toxicity as a 
result of irrigation (50-52). However, these adverse effects could not be 
substantiated in clinical trials (29-35) (41). When considering antibiotics, the 
bactericidal effect of most agents requires a substantial interval of contact time. It is 
unlikely that pIOWI with antibiotic solutions is performed with sufficient time to 
achieve clinical efficacy, and anaphylactic reactions are reported (53).  In addition, 
the misuse of antibiotics is considered to be a major driving force to the emergence 
of antimicrobial resistance (54-56). In contrast, resistance of organisms against 
antiseptics is suggested to be low, possibly due to their multiple pharmacological 
targets (57, 58).  Wound irrigation using aqueous chlorhexidine (CHX) may be an 
alternative, when extrapolating the favourable results from alcohol-based CHX used 
for preoperative skin preparation, but clinical data are lacking. The results of 
aqueous 0.05% chlorhexidine gluconate as wound irrigation fluid in laboratory and 
animal studies are promising (59, 60). 
 
Previous meta-analyses have assessed the effect of pIOWI but with serious 
limitations in their study selection impeding extrapolation to current clinical practice. 
Fournel et al. (61) have performed a systematic review of PVP-I in various 
applications and found a reduction of the incidence of SSI after aqueous PVP-I 
irrigation. Mueller et al. (8) have systematically assessed pIOWI with saline, PVP-I 
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and antibiotic solutions, and concluded that both PVP-I and antibiotic irrigation 
where effective in the reduction of SSI. However, both these reviews have included 
studies investigating IOWI as therapeutic measure for existing infections rather than 
as a preventive measure, and studies investigating IOWI while current standards of 
systemic antibiotic prophylaxis were not met. Fournel et al. (61) conducted a 
subgroup analysis of studies with standard systemic antibiotic prophylaxis but left 
relevant studies out (29, 30, 35). Mueller et al. has included PVP-I powder (spray) 
application among IOWI studies using an irrigation solution, but the mechanical 
effect of removal and dilution of the bacterial load is not achieved by powder 
application. Present systematic review specifically investigates the prophylactic 
effect of IOWI on the incidence of SSI against the background of current standard of 
care.  
The limitations of the present study are generally allocated to the individual studies.  
The individual sample sizes are small resulting in little power per study and a high 
risk of failing to detect a true effect (β or type-two error). By conducting a meta-
analysis, the power is increased and the risk of failing to detect a true effect reduced. 
Published studies on pIOWI are mostly conducted in the 1980s, which may represent 
a limitation as infection prevention and control measures have changed substantially 
since that period. Similarly, standards for the conduct and reporting of clinical trials 
have changed resulting in a stringent assessment of the quality of evidence. Strict 
inclusion criteria has limited the total of identified studies to 21 RCTs. Variation is 
seen in definition of SSI and follow up duration (appendix B)  as the widely accepted 
definition of the CDC was first published in 1999 (15). Therefore, SSIs may be over- 
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or underreported. And finally, the exposure times and application methods were 
heterogeneous.   
In absence of a proven effect of antibiotic irrigation and based on the risk of 
emerging antimicrobial resistance associated with the unnecessary use of antibiotics, 
irrigation with antibiotic solution should be avoided. Low quality evidence suggests 
benefit from incisional wound irrigation with aqueous povidone iodine. New high 
quality RCTs are needed but might not have priority considering the relatively large 
effect of prophylactic incisional wound irrigation using aqueous povidone iodine. A 
combined approach of several interventions to reduce SSIs may be more favourable 
since it has become apparent that a bundle approach has been successful in some 
studies (62-64).  
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Figure Legend 
Figure 1: PRISMA flow chart of the systematic review 
Figure 2a: Forrest plot of incisional wound irrigation with aqueous povidone-iodine 
vs. saline irrigation 
Figure 2b: Forrest plot of incisional wound irrigation with aqueous povidone-iodine 
vs. saline irrigation stratified by wound contamination 
Figure 2c: Forrest plot of incisional wound irrigation with aqueous povidone-iodine 
vs. saline irrigation stratified by povidone-iodine solution. 
Figure 3: Forrest plot of incisional wound irrigation with antibiotic vs. saline 
irrigation, or no irrigation. 
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Table 1. Explanatory table of definitions used 
Prophylactic 
intraoperative 
wound irrigation 
(pIOWI) 
The flow of a solution across the surface of an open wound to achieve wound 
hydration. It physically removes and dilutes body fluids, bacteria and cellular 
debris and additionally has a bactericidal effect when additives as antibiotics 
or antiseptic agents are used 
Intraoperative 
wound irrigation 
as therapeutic 
intervention 
CDC Wound class IV was considered a pre-existent infection; irrigation field 
was considered to be therapeutic not prophylactic 
 
Intraoperative 
wound irrigation 
as prophylactic 
intervention 
CDC wound class I-III was considered potentially contaminated; irrigation was 
considered to be prophylactic  
Irrigation of the newly made incisional wound was always considered 
prophylactic, regardless of the wound classification, as the incisional wound 
did not exist prior to the procedure and pre-existent wound infection was 
impossible. 
Syringe pressure 
irrigation 
Solution delivered with a syringe with an intravenous catheter applying force 
by hand. 
Pulse pressure 
irrigation 
Irrigation with the use of a mechanical device that delivers pulsatile saline 
irrigation. 
US Centers for 
Disease Control 
and Prevention 
(CDC) wound 
classification 
Class I/Clean: An uninfected operative wound in which no inflammation is 
encountered and the respiratory, alimentary, genital, or uninfected urinary 
tract is not entered. In addition, clean wounds are primarily closed and, if 
necessary, drained with closed drainage. Operative incisional wounds that 
follow nonpenetrating (blunt) trauma should be included in this category if 
they meet the criteria. 
Class II/Clean-Contaminated: An operative wound in which the respiratory, 
alimentary, genital, or urinary tracts are entered under controlled conditions 
and without unusual contamination. Specifically, operations involving the 
biliary tract, appendix, vagina, and oropharynx are included in this category, 
provided no evidence of infection or major break in technique is 
encountered. 
Class III/Contaminated: Open, fresh, accidental wounds. In addition, 
operations with major breaks in sterile technique (e.g., open cardiac 
massage) or gross spillage from the gastrointestinal tract, and incisions in 
which acute, nonpurulent inflammation is encountered are included in this 
category. 
Class IV/Dirty-Infected: Old traumatic wounds with retained devitalized 
tissue and those that involve existing clinical infection or perforated viscera. 
This definition suggests that the organisms causing postoperative infection 
were present in the operative field before the operation. 
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Table 2: summary evidence table 
Study Type of 
surgery 
Irrigati
on 
surfac
e 
Intervention Control Follow
-up 
Primary outcome  Results 
Tanaka 
 201518 
Elective 
liver 
resection 
PC 1000-3000mL warm sterile 
saline solution directed at 
the dissected area 
 
 
No 
irrigation 
28 
days 
Incisional: 
clinically- apparent 
cellulitis, induration or 
purulent discharge 
from the closure site.  
 
Organ/space: 
radiological evidence of 
fluid collection 
necessitating drainage or 
antibiotic therapy 
Total 
I: 21/96 
C: 13/97 
 
Incisional I:7/96 
C: 6/97 
 
Abscess 
I: 16/96 
C: 7/97 
Baker  
199419 
Elective 
colorectal 
surgery 
PC 250 mL taurolidine 2% in 
PVP-I 5%. 
Diluted in 250 mL saline 
solution 
followed by suction 
500mL 
saline 
solution 
followed 
by suction 
6 
weeks 
Spontaneous or incisional 
discharge from the 
wound 
with an infective 
organism  
identified on culture 
Total: 
I: 17/150 
C: 17/150 
 
Incisional 
I: 17/150 
C: 17/150 
 
Abscess 
I: 2/150 
C: 1/150 
Freischlag  
198420 
Elective 
biliary 
operations 
IW & 
PC 
Cefamandole nafate 0.4% 
solution (4 gm in 1000 mL 
normal saline solution) 
No 
irrigation 
30 
days 
Wound and intra-
abdominal infections 
were defined 
by the spontaneous or 
surgical drainage of pus. 
Total 
I: 1/26 
C: 0/36 
 
SSI 
I: 1/26 
C: 0/36 
 
Abscess 
I: 0/26 
C: 0/36 
Silverman  
198621 
Elective or 
emergency 
trans-
peritoneal 
intestinal 
surgery 
PC 2 L 0.9% Sterile saline 
solution containing 
2 g tetracycline 
Sterile 
saline 
solution 
irrigation 
6 
weeks  
Wound infection:  
Pus discharge from the 
wound. 
 
Intra-abdominal abscess: 
a mass palpable / 
identified radiologically 
plus spontaneous 
discharge  
/requiring surgical 
drainage. 
Total 
I: 15/85 
C: 25/74 
 
SSI 
I :10/85 
C: 24/74 
 
Abscess 
I: 11/85 
C: 10/74 
Ruiz Tovar 
201222 
Colorectal 
surgery 
PC Saline solution followed by 
a second lavage with  
gentamicin (240 mg) -
clindamycin (600 mg) 
solution  
Saline 
solution 
irrigation 
30 
days 
Purulent 
discharge from the 
surgical wound confirmed 
by 
microbiological culture 
SSI  
I: 2/51 
C: 10/51 
 
Incisional  
I: 2/51 
C: 7/51 
 
Abscess 
I: 0/51 
C: 3/51 
Al Ramahi  
200623 
Caesarean 
sections 
IW 50 mL normal saline 
solution 
No 
irrigation 
4 
weeks 
Discontinuation 
associated with 
purulent discharge and 
local tenderness, hotness 
and/or redness 
SSI 
I: 11/104 
C: 10/102 
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Cervantes- 
Sanchez  
200024 
Appendect
omy 
IW 300 mL saline solution 
delivered with a 20 mL 
syringe with a 1- gauge 
intravenous catheter 
applying the force of one 
hand at a distance of 2 cm 
from the wound 
No 
irrigation 
4 
weeks 
Clear collection of pus, 
which empties itself 
spontaneously or after 
incision 
SSI 
I: 11/127 
C: 39/156 
 
Hargrove  
200625 
Orthopaedi
cs 
IW 2 L pulse lavage saline 2 L saline 
via syringe 
Discha
rge/ 
30 
days 
CDC SSI 
I: 9/164 
C: 30/192 
Nikfarjam 
201426 
Laparotom
y 
extending 
2 hours   
IW 
 
 
Pressurized pulse lavage 
15 psi  
 
Surgical irrigation device 
(Medline Industries, 
Mundelein, IL, USA) 
Normal  30 
days 
CDC  SSI 
I:4/68 
C: 12/62 
Rogers  
198327  
General 
surgery 
IW 60-second irrigation with a 
PVP-I 10% solution 
Saline 
solution 
1 
month 
Purulent discharge. SSI 
I: 04/86 
C: 11/101 
Sindelar  
197928 
General 
surgery 
IW 60-second irrigation with a 
PVP-I 10% solution 
Saline 
solution 
12 
weeks 
If any amount of pus was 
discharged/ serous 
drainage with bacterial 
growth 
SSI 
I: 7/242 
C: 39/258 
Sindelar * 
198529 
Intra-
abdominal 
surgery 
IW  IW: PVP-I 10% Saline 
solution in 
PC 
 
Saline 
solution in 
IW 
NR 
mean 
hospit
alizatio
n > 3 
weeks 
NR SSI 
I: 1/37 
C: 3/38 
 
 
Lau  
198630 
 
Appendect
omy 
IW 10-minute irrigation with a 
PVP-I 1% solution 
No 
irrigation 
6 
weeks 
Clear collection of pus, 
which empties itself 
spontaneously or after 
incision 
SSI 
I: 9/159 
C: 3/156 
Chang  
200631 
Spine 
surgery 
IW 180-second irrigation with 
PVP-I 0.35%, followed by 
copious irrigation with a 
normal saline solution 
Irrigation 
with a 
copious 
saline 
solution 
19.4 
month 
All deep infections were 
confirmed by laboratory 
parameters, including the 
erythrocyte 
sedimentation rate and 
level of C-reactive 
protein and a positive 
culture of biopsy 
SSI 
I: 0/120 
C: 6/124 
Cheng  
200532 
Spine 
surgery 
IW 180-second irrigation with 
PVP-I 0.35%, followed by 
copious irrigation with a 
normal saline solution 
Irrigation 
with a 
copious 
saline 
solution 
15.5 
month 
Infection suspected when 
unusual pain, tenderness, 
erythema, induration, 
fever or wound drainage 
was observed. Confirmed 
by erythrocyte 
sedimentation rate, C-
reactive protein and 
bacteriological 
cultures from the 
operative site or blood 
SSI 
I: 0/ 208 
C: 7/ 206 
Kokavec  
200833 
Orthopaedi
c 
IW  PVP-I 0.35% Saline 
solution 
7.8 
month 
Pain, redness, swelling 
and increased 
temperature of the 
wound 
SSI 
I: 0/89 
C: 2/73 
Juul  
198534 
Elective 
colorectal 
surgery 
IW Ampicillin 1 g in 10 ml 
saline solution 
No further 
prophylac
tic 
treatment 
Until 
suture
s 
remov
ed 
Accumulation of pus 
requiring surgical 
drainage 
SSI 
I: 5/105 
C: 5/98 
Moesgaard 
198935 
Intra-
abdominal 
surgery 
IW Cefotaxime 2 g applied 
topically to the 
subcutaneous layer at the 
time of wound closure. 
 
No 
irrigation 
1 
Month 
Wound infection: 
accumulation of pus, 
draining spontaneously/ 
after opening the wound.  
 
IA: proven by 
Total 
I: 19/87 
C: 19/90 
 
SSI 
I: 15/87 
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surgical drainage or by 
ultrasound-guided 
aspiration. 
C: 14/90 
 
Abscess 
I: 4/87 
C: 5/90 
Pitt  
198036 
Vascular 
surgery 
IW Cephradine (1.0 g) 
dissolved in 25 ml of saline 
solution 
Saline 
solution 
irrigation 
4 
weeks 
Purulent material 
drained from the incision 
without evidence of prior 
ischemia of the skin 
edges. 
SSI 
I: 3/51 
C: 0/55 
Ruiz Tovar 
201337 
Lymph 
node 
dissection 
IW Normal saline solution plus 
Gentamicin 240 mg in 500 
mL 
Saline 
irrigation 
NR Wound infection SSI 
I: 0/20 
C: 0/20 
Ko  
199238 
Cardiac 
bypass 
surgery 
MC 
 
 
Irrigation with a PVP-I 
0.5% solution 
Irrigation 
with a 
saline 
solution 
30 
days 
Mediastinitis. Pain, fever, 
erythema, drainage, 
sternal instability, 
tenderness on palpation 
and leukocytosis.  
Occasionally, mediastinal 
aspiration or CT was 
needed. Subcutaneous 
wound problems were 
not included 
Mediastinal 
SSI 
 
I: 11/990 
C: 6/990 
CDC: Centers for Disease Control and Prevention; IW: incisional wound; PC: peritoneal cavity; NR: not reported; NA: not applicable; PVP-I:  
aqueous povidone-iodine; SSI: surgical site infection; I: intervention; C: control; LMW: low molecular weight 
* This study described peritoneal irrigation as well as incisional wound irrigation. However, intra-abdominal infections were not included in 
the analyses since infection of this field was pre-existent. 
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Table 3: Risk of bias table 
Author Sequence 
generation 
Allocation 
concealment 
Blinding of 
patients 
and staff 
Blinding of 
outcome 
assessors    
Incomplete 
outcome data 
Selective 
reporting 
Other 
bias 
Tanaka 201518 Low Low  High High Low Low Low 
Baker 199419 Low Low Low Low Low Low Low 
Freischlag 
198420 
Low High Unclear Unclear Low Low Low 
Silverman 
198621 
Low Low Unclear Low Low High Low 
Ruiz Tovar 
201222 
Low Low Unclear Low  High Low Low 
Al-Ramahi 
200623 
High High High High Low Low Low 
Cervantes-
Sánchez 
200024 
Low Low High Low Low Low Low 
Hargrove 
200625 
Unclear Unclear Unclear Unclear High Low Low 
Nikfarjam 
201426 
Low Unclear High High Low Low Low 
Rogers 198327 High High High Unclear Low Low Low 
Sindelar 
197928 
Unclear Unclear High Unclear Low Low Low 
Sindelar 
198529 
Unclear Unclear High Unclear Low Low Low 
Lau 198630 Unclear Unclear High Low Low Low Low 
Chang 200631 Low Unclear High Low Low Low Low 
Cheng 200532 Low Unclear High Low Low Low Low 
Kokavec 
200833 
Unclear Unclear Unclear Unclear Low Low Low 
Juul 198534 Low High Unclear Unclear Low Low Low 
Moesgaard 
198935 
Unclear High High Low  Low Low Low 
Pitt 198036 Unclear Unclear Unclear Low Low Low Low 
Ruiz Tovar 
201337 
Low Low Unclear  Unclear Low High Low 
Ko 199238 High High Unclear Unlcear Low Low Low 
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Appendix A: Search terms 
 
 
  
MEDLINE 
 
1. "surgical wound infection"[Mesh] OR surgical site infection*[tiab] OR SSI[tiab] OR SSIs[tiab] OR 
surgical wound infection*[tiab] OR surgical infection*[tiab] OR post-operative wound 
infection*[tiab] OR postoperative wound infection*[tiab] 
2.  irrigat*[tiab]) OR lavag*[tiab]) OR spray*[tiab]) OR soak*[tiab]) OR rins*[tiab] OR "therapeutic 
irrigation"[Mesh] 
3. trial[ti]) OR randomly[tiab]) OR clinical trial as topic[mesh:noexp]) OR placebo[tiab]) OR 
randomized[tiab]) OR controlled clinical trial[pt]) OR randomized controlled trial[pt] 
4. 1 AND 2 AND 3 
EMBASE 
 
1. exp surgical infection/ or (SSI or SSIs).ti,ab,kw. or ((surg* or postoperat* or post-operat*) adj3 
infect*).ti,ab,kw 
2. wound irrigation / or lavage/ or (irrigat* or lavag* or spray* or soak* or rins*).ti,ab,kw. 
3. controlled clinical trial/ or randomized controlled trial/ or exp "clinical trial (topic)"/ or 
(randomly or randomized or placebo).ti,ab,kw. or trial.ti. 
4. 1 AND 2 AND 3 
COCHRANE 
REGISTER 
(CENTRAL) 
 
1. MeSH descriptor: [surgical wound infection] explode all trees 
2. SSI or SSIs:ti,ab,kw  (word variations have been searched) 
3. (surg* or postoperat* or post-operat*) near/3 infect*:ti,ab,kw  (word variations have been 
searched) 
4. 1 OR 2 OR 3 
5. irrigat* or lavag* or spray* or soak* or rins*:ti,ab,kw  (word variations have been searched) 
6. 4 AND 5 
CINAHL 
 
1.  (MH "surgical wound infection") OR ( TI ( surgical site infection* OR SSI OR SSIs OR surgical 
wound infection* OR surgical infection* OR post-operative wound infection* OR postoperative 
wound infection* ) OR AB ( surgical site infection* OR SSI OR SSIs OR surgical wound infection* 
OR surgical infection* OR post-operative wound infection* OR postoperative wound infection* 
) ) 
2. (MH "therapeutic irrigation") OR TI ( irrigat* or lavag* or spray* or soak* or rins* ) OR AB ( 
irrigat* or lavag* or spray* or soak* or rins* )  
3. (MH "randomized controlled trials") OR (MH "clinical trials+") OR TI trial OR ( TI controll* AND 
trial* ) OR AB ( TI controll* AND trial* ) OR (TI (randomly OR placebo OR randomi?ed ) OR AB ( 
randomly OR placebo OR randomi?ed ) ) 
4. S1 AND S2 AND S3 
WHO Global 
Regional Medical 
Databases 
 
1. (SSI) 
2. (surgical site infection)  
3. (surgical site infections)  
4. (wound infection)  
5. (wound infections) 
6. (postoperative wound infection) 
7. (irrigation) 
8. (lavage) 
Abbreviations: ti: title; ab: abstract: kw: keywords. 
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Appendix B: Evidence table 
Refe
renc
e 
Design, 
scope, 
participa
nts (no) 
Type of 
surgery 
CDC 
woun
d 
classif
icatio
n 
Irrig
atio
n 
surf
ace 
Intervention Control Foll
ow
-up 
Primary 
outcome  
Resu
lts 
Adver
se 
event
s 
Tana
ka 
2015
18 
RCT 
single 
centre 
193 
Elective 
liver 
resection 
without 
reconstru
ction of 
bile duct 
or small 
intestine 
II PC Irrigation with 
1000-3000 mL 
warm sterile 
saline 
solution 
directed at 
the dissected 
area. 
 
Both groups 
used wound 
washout with 
a warm sterile 
saline 
solution 
No 
irrigatio
n 
28 
day
s 
Incisional: 
clinically- 
apparent 
cellulitis, 
induration or 
purulent 
discharge 
from the closure 
site.  
 
Organ/space: 
radiological 
evidence of fluid 
collection 
necessitating 
drainage 
or antibiotic 
therapy. 
SSI 
I: 
21/9
6 
C: 
13/9
7 
 
Incisi
onal: 
7/96 
C: 
6/97 
 
Absc
ess 
I: 
16/9
6 
C: 
7/97 
NR 
Bake
r 
1994
19 
RCT 
single 
centre 
330 
 
Elective 
colorectal 
surgery 
II PC 250 mL 
taurolidine 
2% in PVI 5%. 
 
Diluted in 250 
mL saline 
solution 
followed by 
suction 
250 mL 
saline 
solution 
 
Diluted 
in 250 
mL 
saline 
solution 
 
followed 
by 
suction 
6 
we
eks 
Spontaneous or 
incisional 
discharge from 
the wound 
with an infective 
organism  
identified on 
culture. 
Total
: 
I: 
17/1
50 
C: 
17/1
50 
 
Absc
ess 
I: 
2/15
0 
C: 
1/15
0 
 
Incisi
onal 
I: 
17/1
50 
C: 
17/1
50 
NR 
Freis
chla
g 
1984
20 
RCT 
single 
centre 
62  
Elective 
billary 
operation
s 
II-III IW 
& 
PC 
Cefamandole 
nafate 0.4% 
solution (4 gm 
in 1000 mL 
normal saline 
solution) 
No 
irrigatio
n 
30 
day
s 
Wound and 
intra-abdominal 
infections were 
defined 
by the 
spontaneous or 
surgical drainage 
SSI 
I: 
1/26 
C: 
0/36 
 
Absc
ess 
NR 
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of pus. I: 
0/26 
C: 
0/36 
Total 
I: 
1/26 
C: 
0/36 
 
Silve
rma
n 
1986
21 
RCT 
single 
centre 
159 
Elective 
or 
emergen
cy trans-
peritonea
l 
intestinal 
surgery 
II-III  PC 2 L 0.9% 
Sterile  saline 
solution 
containing 
2 g 
tetracycline 
Sterile 
saline 
solution 
irrigatio
n 
6 
we
eks  
Wound 
infection:  
Pus discharge 
from the wound. 
 
IA abscess: a 
mass palpable / 
identified 
radiologically 
plus 
spontaneous 
discharge  
/requiring 
surgical 
drainage. 
SSI 
I 
:10/8
5 
C: 
24/7
4 
 
Absc
ess 
I: 
11/8
5 
C: 
10/7
4 
 
Total 
I: 
15/8
5 
C: 
25/7
4 
NR 
Ruiz 
Tova
r 
2012
22 
RCT 
single 
centre 
103 
Colorecta
l surgery 
II-III PC Saline 
solution 
followed by a 
second lavage 
with  
gentamicin 
(240 mg) -
clindamycin 
(600 mg) 
solution  
Saline 
solution 
irrigatio
n 
30 
day
s 
Purulent 
discharge from 
the surgical 
wound 
confirmed by 
microbiological 
culture. 
SSI  
I: 
2/51 
C: 
10/5
1 
 
Incisi
onal  
I: 
2/51 
C: 
7/51 
 
Absc
ess 
I: 
0/51 
C: 
3/51 
NR 
Al 
Ram
ahi 
2006
23 
RCT 
single 
centre 
206 
Caesarea
n section 
II IW 50 mL normal 
saline 
solution 
No  
wound 
irrigatio
n 
4 
we
eks 
Discontinuation 
associated with 
purulent 
discharge and 
local tenderness, 
hotness and/or 
redness 
SSI 
I: 
11/1
04 
C: 
10/1
02 
NR 
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Cerv
ante
s-
Sanc
hez 
2000
24 
RCT 
single 
centre 
283 
Appende
ctomy 
II-IV 
 
 
IW 300 mL saline 
solution 
delivered with 
a 20 mL 
syringe with a 
1- gauge 
intravenous 
catheter 
applying the 
force of one 
hand at a 
distance of 2 
cm from the 
wound 
No 
irrigatio
n 
4 
we
eks 
Clear collection 
of pus, which 
empties itself 
spontaneously 
or after incision, 
SSI 
I: 
11/1
27 
C: 
39/1
56 
 
NR 
Harg
rove 
2006
25 
 
RCT 
multicen
tre 
356 
Orthopae
dics 
I IW 2 L pulse 
lavage saline 
2 L 
saline 
via 
syringe 
Dis
cha
rge
/ 
30 
day
s 
CDC SSI 
I: 
9/16
4 
C: 
30/1
92 
 
 
 
 
Nikf
arja
m 
2014
26 
RCT 
multicen
tre 
128 
Laparoto
my 
extending 
2 hours  
(hepato-
pancreat
o-biliary)  
II-III IW 
 
Bot
h 
gro
ups: 
lava
ge 
of 
the 
PC 
wit
h a 
war
m 
sali
ne 
solu
tion 
 
Pressurized 
pulse lavage 
15 psi  
 
Surgilav 
irrigation 
device 
(Medline 
Industries, 
Mundelein, IL, 
USA) 
 
 
 
Normal  30 
day
s 
CDC  SSI 
I:4/6
8 
C: 
12/6
2 
NR 
Roge
rs 
1983
27  
RCT 
single 
centre 
187 
General 
surgery 
I-IV 
differ
entiat
ed 
IW 60-second 
irrigation with 
a PVI 10% 
solution 
Saline 
solution 
1 
mo
nth 
Purulent 
discharge. 
SSI 
I: 
04/8
6 
C: 
11/1
01 
No AE 
Sind
elar 
1979
28 
RCT 
single 
centre 
500 
Abdomin
al, 
gastroint
estinal, 
oncologic
, 
vascular, 
head and 
neck, 
thoracic, 
genitouri
nary, 
trauma 
I-IV 
 
 
IW 60-second 
irrigation with 
a PVI 10% 
solution 
Saline 12 
we
eks 
If any amount of 
pus was 
discharged/  
serous drainage 
with bacterial 
growth. 
SSI 
I: 
7/24
2 
C: 
39/2
58 
No AE 
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Sind
elar 
1985
29 
RCT 
single 
centre 
75 
Intra-
abdomin
al surgical 
procedur
es 
III-IV PC 
& 
IW 
3 x 30-60 
second  
irrigation with 
sterile LMW 
PVI 1% 
solution 
followed by 
suction (last 
irrigation 
immediately 
prior to 
closure.DSC: 
PVI 10% 
Saline 
solution 
in PC 
 
Saline 
solution 
in IW 
NR 
me
an 
hos
pita
liza
tio
n > 
3 
we
eks 
NR SSI 
I: 
1/37 
C: 
3/38 
Absc
ess 
I: 
1/37 
C: 
7/38 
 
Total 
I: 
2/37 
C: 
10/3
8 
 
 
No AE 
 
(brief 
iodin
e 
eleva
tion 
but 
no 
signs 
of 
toxici
ty) 
Lau 
1986
30 
RCT 
single 
centre 
315 
Appende
ctomy 
II-IV IW 10-minute 
irrigation with 
a PVI 1% 
solution 
No 
irrigatio
n 
6 
we
eks 
Clear collection 
of pus, which 
empties itself 
spontaneously 
or after incision 
SSI 
I: 
9/15
9 
C: 
3/15
6 
NR 
 
 
 
Chan
g 
2006
31 
RC 
Single 
centre 
244 
Spine I IW 
180-second 
irrigation with 
PVI 0.35%, 
followed by 
copious 
irrigation with 
a normal 
saline 
solution 
Irrigatio
n with a 
copious 
saline 
solution 
19.
4 
mo
nth 
All deep 
infections were 
confirmed by 
laboratory 
parameters, 
including the 
erythrocyte 
sedimentation 
rate and level of 
C-reactive 
protein and a 
positive culture 
of biopsy. 
SSI 
I: 
0/12
0 
C: 
6/12
4 
 NR; 
no 
differ
ence 
on 
fusio
n 
rate, 
functi
on or 
pain 
Chen
g 
2005
32 
RCT 
single 
centre 
414 
Spine 
surgery 
I IW 180-second 
irrigation with 
PVI 0.35%, 
followed by 
copious 
irrigation with 
a normal 
saline 
solution 
Irrigatio
n with a 
copious 
saline 
solution 
15.
5 
mo
nth 
Infection was 
suspected when 
unusual pain, 
tenderness, 
erythema, 
induration, fever 
or wound 
drainage was 
observed. 
Confirmed by 
erythrocyte 
sedimentation 
rate, C-reactive 
protein and 
bacteriological 
cultures from 
the operative 
SSI 
I: 0/ 
208 
C: 7/ 
206 
No AE 
 
No 
effect 
on 
union 
time 
or 
qualit
y of 
bony 
fusio
n was 
noted
. 
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site or blood. 
 
No 
allerg
y 
Koka
vec 
2008
33 
RCT 
single 
centre 
162 
Orthopae
dic 
I IW  PVI 0.35% Saline 7.8 
mo
nth 
Pain, redness, 
swelling and 
increased 
temperature of 
the wound. 
SSI 
I: 
0/89 
C: 
2/73 
NR 
Juul 
1985
34 
RCT 
single 
centre 
203 
Elective 
colonic 
and 
rectal 
surgery 
II-III IW Ampicillin 1 g 
in 10 ml saline 
solution 
No 
further 
prophyl
actic 
treatme
nt 
Unt
il 
sut
ure
s 
wer
e 
re
mo
ved 
Accumulation of 
pus requiring 
surgical 
drainage, 
SSI 
I: 
5/10
5 
C: 
5/98 
No AE 
Moe
sgaa
rd 
1989
35 
RCT 
single 
centre 
1989 
Intra-
abdomin
al 
operation 
IV IW Cefotaxime 2 
g applied 
topically to 
the 
subcutaneous 
layer at the 
time of 
wound 
closure. 
 
No 
irrigatio
n 
1 
Mo
nth 
Wound 
infection: 
accumulation of 
pus, draining 
spontaneously/ 
after opening 
the wound. IA: 
proven by 
surgical drainage 
or by 
ultrasound-
guided 
aspiration. 
SSI 
I: 
15/8
7 
C: 
14/9
0 
 
Absc
ess 
I: 
4/87 
C: 
5/90 
 
Total 
I: 
19/8
7 
C: 
19/9
0 
 
NR 
Pitt 
1980
36 
RCT 
ingle 
centre 
106 
Vascular 
surgery 
I IW Cephradine 
(1.0 g) 
dissolved in 
25 ml of 
saline 
solution 
Saline 
solution 
irrigatio
n 
4 
we
eks 
Purulent 
material 
drained from the 
incision without 
evidence of prior 
ischemia of the 
skin edges. 
SSI 
I: 
3/51 
C: 
0/55 
NR 
Ruiz 
Tova
r 
2013
37 
RCT 
single 
centre 
40 
Lymph 
node 
dissectio
n 
I IW Normal saline 
solution plus 
Gentamicin 
240 mg in 500 
mL  
Saline 
irrigatio
n 
NR Wound 
infection. 
SSI 
I: 
0/20 
C: 
0/20 
NR 
Ko 
1992
38 
RCT 
single 
cente 
1980 
 
Cardiac 
bypass 
surgery 
I MC 
 
Sub
cuta
neo
us 
wo
und 
Irrigation with 
a PVI 0.5% 
solution 
Irrigatio
n with a 
saline 
solution 
30 
day
s 
Mediastinitis. 
Pain, fever, 
erythema, 
drainage, sternal 
instability, 
tenderness on 
palpation and 
leukocytosis.  
Medi
astin
al 
SSI 
I: 
11/9
90 
NR 
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was 
copi
ousl
y 
irrig
ate
d 
bef
ore 
skin 
clos
ure 
Occasionally, 
mediastinal 
aspiration or CT 
was needed.  
Subcutaneous 
wound problems 
were not 
included 
C: 
6/99
0 
CDC: Centers for Disease Control and Prevention; IW: incisional wound; PC: peritoneal cavity; NR: not reported; NA: not 
applicable; PVI: povidone-iodine; AE: adverse event; SSI: surgical site infection; I: intervention; C: control; RCT: randomized 
controlled trial; LMW: low molecular weight; 
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Appendix D. All comparisons  
 
Comparison 1: Intraperitoneal irrigation: Saline solution vs. no irrigation 
 
*Meta-analysis of one study does not comprise actual pooled data, but is included 
for purposes of illustration. 
 
Funnelplot not applicable 
 
 
Comparison 2: Intraperitoneal irrigation: Taurolidine 2% vs. saline solution* 
 
*Meta-analysis of one study does not comprise actual pooled data, but is included 
for purposes of illustration. 
 
 Funnelplot not applicable  
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Comparison 3: Intraperitoneal irrigation: Antibiotic vs. saline or no 
irrigation 
 
Funnelplot:  
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Comparison 4: Incisional wound irrigation: Saline solution vs. no irrigation 
 
*Meta-analysis of one study does not comprise actual pooled data, but is included 
for purposes of illustration 
 
Funnelplot not applicable 
 
 
Comparison 5: Incisional wound irrigation: Syringe pressure saline vs. no 
irrigation* 
 
 
*Meta-analysis of one study does not comprise actual pooled data, but is included 
for purposes of illustration 
 
Funnelplot not applicable 
 
 
Comparison 6: Incisional wound irrigation: Pulse pressure irrigation 
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Funnelplot: 
Comparison 7: Incisional wound irrigation: Aqueous povidone-iodine vs. 
saline irrigation 
 
- Stratified by povidone-iodine solution (7a) 
 
 
- Stratified by wound contamination class (7b) 
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Funnelplot:  
 
  
Published in final edited form as:  
Surg Infect (Larchmt). 2017 May/Jun;18(4):508-519. doi: 10.1089/sur.2016.272 
49 
 
Comparison 8: Incisional wound irrigation: antibiotic vs. saline irrigation, or 
no irrigation 
 
 
 Funnelplot: 
 
 
Comparison 9: Mediastinal irrigation: povidone-iodine 0.5% vs. saline 
irrigation* 
 
 
*Meta-analysis of one study does not comprise actual pooled data, but is included 
for purposes of illustration 
 
M-H: Mantel-Haenszel (test); CI: confidence interval 
 
Funnelplot not applicable 
 
 
